Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
6.00
-0.04 (-0.66%)
Apr 21, 2026, 4:00 PM EDT - Market closed
Valneva SE Market Cap
Valneva SE has a market cap or net worth of $535.43 million as of April 21, 2026. Its market cap has increased by 1.28% in one year.
Market Cap
535.43M
Enterprise Value
650.44M
1-Year Change
1.28%
Ranking
Category
Stock Price
$6.00
Market Cap Chart
Since the IPO on June 3, 2014, Valneva SE's market cap has increased from $450.94M to $535.43M, an increase of 18.73%. That is a compound annual growth rate of 1.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 535.43M | -29.00% |
| Dec 31, 2025 | 754.16M | 107.47% |
| Dec 31, 2024 | 363.50M | -49.80% |
| Dec 29, 2023 | 724.08M | -21.32% |
| Dec 30, 2022 | 920.30M | -68.57% |
| Dec 31, 2021 | 2.93B | 239.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AgomAb Therapeutics NV | 552.19M |
| Fulcrum Therapeutics | 552.12M |
| Zura Bio | 551.26M |
| Immix Biopharma | 548.68M |
| Absci | 547.82M |
| ADC Therapeutics | 543.75M |
| Upstream Bio | 543.66M |
| enGene Therapeutics | 540.60M |